Continuous Ketone Monitoring (CKM) Market Analysis and Forecast to 2036 | Industry to Reach US$5.48 Billion as AID Integration and Dual Sensors Accelerate
The global continuous ketone monitoring market is projected to grow from USD 18.5 million in 2025 to USD 5.48 billion by 2036, with a CAGR of 46.8%. Abbott leads the market as the first company to receive FDA and CE approvals for dual glucose-ketone sensors. Growth is driven by rising DKA incidence, SGLT2 inhibitor adoption, and integration with automated insulin delivery systems, though limited product availability and reimbursement uncertainty remain constraints.
